What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 117-122

  Braun Moscovici, Yolanda ^a   Braun, Marius ^b   Khanna, Dinesh ^c   Balbir Gurman, Alexandra ^a   Furst, Daniel E ^d  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastro intestinal tract; Systematic literature review; Systemic sclerosis

Indexed keywords

FAT; HYDROGEN; LACTULOSE; METHANE; XYLOSE; BIOLOGICAL MARKER;

ARTICLE; BACTERIAL OVERGROWTH; BACTERIUM CULTURE; BREATH ANALYSIS; DIAGNOSTIC TEST; FEASIBILITY STUDY; FECAL FAT TEST; FECES ANALYSIS; HUMAN; HYDROGEN BREATH TEST; INTERMETHOD COMPARISON; INTESTINE EXAMINATION; JEJUNUM; LACTULOSE TEST; MALABSORPTION; METHANE BREATH TEST; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; SYSTEMIC SCLEROSIS; VALIDATION STUDY; XYLOSE TEST; BACTERIUM; BLIND LOOP SYNDROME; CHEMISTRY; COMPLICATION; DIGESTIVE SYSTEM EXAMINATION; FECES; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; SMALL INTESTINE;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BIOLOGICAL MARKERS; BLIND LOOP SYNDROME; BREATH TESTS; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; FECES; FERMENTATION; HUMANS; HYDROGEN; INTESTINE, SMALL; LACTULOSE; METHANE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC;

EID: 84946204390     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. SJöGREN RW: Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994; 37: 1265-82.
2. SJöGREN RW: Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996; 8: 569-75.
3. LOCK G, HOLSTEGE A, LANG B, SCHOLMERICH J: Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997; 92: 763-71.
4. IOVINO P, VALENTINI G, CIACCI C et al.: Proximal stomach function in systemic sclerosis. Relationship with autonomic nerve function. Dig Dis Sci 2001; 46: 723-30.
5. COHEN S, RISHER R, LIPSHUTZ W, TURNER R, MYERS A, SCHUMACHER R: The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 1972; 51: 2663-8.
6. GOLDBLATT F, GORDON TP, WATERMAN SA: Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterol 2002; 123: 1144-50.
7. KHANNA D, HAYS RD, MARANIAN P et al.: Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum 2009; 61: 1257-63.
8. JAOVISIDHA K, CSUKA ME, ALMAGRO UA, SOERGEL KH: Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. Semin Arthritis Rheum 2008; 34: 689-702.
9. COBDEN I, AXON AT, GHONEIM AT, McGOLDRICK J, ROWELL NR: Small intestinal bacterial growth in systemic sclerosis. Clin Exp Dermatol 1980; 5: 37-42.
10. KAYE SA, LIM SG, TAYLOR M, PATEL S, GILLESPIE S, BLACK CM: Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995; 34: 265-9.
11. COBDEN I, ROTHWELL J, AXON AT, DIXON MF, LINTOTT DJ, ROWELL NR: Small intestinal structure and passive permeability in systemic sclerosis. Gut 1980; 21: 293-8.
12. SALTZMAN JR, KOWDLEY KV, PEDROSA MC et al.: Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994; 106: 615-23.
13. SIMON GL, GORBACH SL: The human intestinal microflora. Dig Dis Sci 1986; 31: 147S.
14. LAUTERBERG BH, NEWCOMER AD, HOFFMAN AF: Clinical value of the bile acid breath test. Mayo Clin Proc 1978; 53: 227-33.
15. METZ G, GASSULL MA, DRASAR BS et al.: Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet 1976; 1: 668-9.
16. FROMM H, THOMAS PJ, HOFMANN AF: Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B12 absorption in ileal resection patients. Gastroenterology 1973; 64: 1077-90.
17. KERLIN P, WONG L: Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988; 95: 982-8.
18. CORAZZA GR, MENOZZI MG, STROCCHI A et al.: The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98: 302-9.
19. RHODES JM, MIDDLETON P, JEWELL DP: The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol 1979; 14: 333-6.
20. GASBARRINI A, CORAZZA GR, GASBARRINI G et al.; 1st Rome H2-BrReathH Ttesting Cconsensus CconferRence WorRking GgrRoup: Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29 (Suppl. 1): 1-49.
21. MARIE I, DUCROTTé P, DENIS P, MENARD JF, LEVESQUE H: Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford) 2009; 48: 1314-9.
22. OWYANG C: Octreotide in gastrointestinal motility disorders. Gut 1994; 35 (Suppl.): S11-4.
23. SOUDAH HC, HASLER WL, OWYANG C: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325: 1461-7.
24. TAUBER M, AVOUAC J, BENAHMED A et al.: Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms. Clin Exp Rheumatol 2014; 32 (Suppl. 86): S82-7.
25. KING C, TOSKES P: Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 1986; 91: 1447-51.
26. RIORDAN S, McIVER C, WALKER B, DUNCOMBE V, BOLIN T, THOMAS M: The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91: 1795-803.
27. HENDEL L, WORNING H: Exocrine pancreatic function in patients with progressive systemic sclerosis. Scand J Gastroenterol 1989 May; 24: 461-6.
28. SACHDEV AH, PIMENTEL M: Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis 2013; 4: 223-31.
29. AKESSON A, AKESSON B, GUSTAFSON T et al.: Gastrointestinal function in patients with progressive systemic sclerosis. Radiology 1986; 160: 73-6.
30. STOTZER P, KILANDER A: Comparison of the 1-gram (14)C-d-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 2000; 61: 165-71.
31. SAVARINO E, FURNARI M, de BORTOLI N et al.: Gastrointestinal involvement in systemic sclerosis. Presse Med 2014; 43: e279-91.
32. HOFMANN AF: The evaluation of bacterial overgrowth in the small intestine: how, when and why. In: PERRI F, ANDRIULLI A, editors. Clinical Application of Breath Tests in Gastroenterology and Hepatology. Rome: International University Press, 1998: 133-7.
33. CASERTA L, de MAGISTRIS L, SECONDULFO M et al.: Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters. Rheumatol Int 2003; 23: 226-30.
34. YU D, CHEESEMAN F, VANNER S: Combined oro-cecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-cecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 2011; 60: 334-40.
35. GEMIGNANI L, SAVARINO V, GHIO M et al.: Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. Semin Arthritis Rheum 2013; 42: 522-9.
36. PARODI A, SESSAREGO M, GRECO A et al.: Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008; 103: 1257-62.
37. SAVARINO E, MEI F, PARODI A et al.: Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford) 2013; 52: 1095-100.
38. SALTZMAN JR, KOWDLEY KV, PEDROSA MC et al.: Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994; 106: 615-23.
39. MINOCHA A, RASHID S: Reliability and reproducibility of breath hydrogen and methane in male diabetic subjects. Dig Dis Sci 1997; 42: 672-6.